GL1X · GenesisL1 explorer

Research workbench

Crystal structure analysis of the complex lfa-1 (CD11A) I-domain / lovastatin at 2.6 a resolution

Analyse Crystal structure analysis of the complex lfa-1 (CD11A) I-domain / lovastatin… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
1CQP
Type
protein
Length
364 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Antigen CD11A (P180)
UniProt
P20701
Ligands
803, MG
Pockets
2 · best druggability 0.64

Structure

x-ray diffraction · 1 distinct chain · 39% helix, 25% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BAntigen CD11A (P180)protein18239% helix, 25% strandP20701

Ligands and binding sites

  • 803 · Lovastatin · ligand · 2 copies · chains A, B
  • MG · Magnesium ion · metal · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12490.640.8121803
22560.630.8022803

Interfaces

1 interface between chains.

  • A–B · 923 Ų buried · 22 hydrogen bonds · protein-protein

Compared structures

  • 1CQP · Crystal structure analysis of the complex lfa-1 (CD11A) I-domain / lovastatin at 2.6 a… · the same entry in another collection · chain A against A, TM-score 1.00
  • P20701 · AlphaFold monomer V2.0 prediction for integrin alpha-L (P20701) · a predicted model of the same protein · chain A against A, TM-score 0.97

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.